Advances and prospects in tumor infiltrating lymphocyte therapy
Abstract Tumor-infiltrating lymphocyte (TIL) therapy in adoptive T-cell therapy (ACT) has already caused durable regression in a variety of cancer types due to T-cell persistence, clinical activity, and duration of objective response and safety. TILs are composed of polyclonal effector T-cells speci...
Tallennettuna:
| Päätekijät: | , , , , , , , |
|---|---|
| Aineistotyyppi: | Artigo |
| Kieli: | Inglês |
| Julkaistu: |
Springer
2024-11-01
|
| Sarja: | Discover Oncology |
| Aiheet: | |
| Linkit: | https://doi.org/10.1007/s12672-024-01410-5 |
| Tagit: |
Ei tageja, Lisää ensimmäinen tagi!
|